Shelton Capital Management Incyte Corp Transaction History

Shelton Capital Management

$3.85 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$63.34 - $74.11 $1.2 Million - $1.41 Million	-19,001 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $2.15 Million - $2.63 Million	-31,277 Reduced 62.21%	19,001 $1.31 Million
Q2 2021 Aug 12, 2021	BUY	$79.87 - $87.53 $4.02 Million - $4.4 Million	50,278 New	50,278 $4.23 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $3.67 Million - $4.86 Million	-48,333 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$74.18 - $108.93 $30,117 - $44,225	406 Added 0.85%	48,333 $5.03 Million
Q1 2020 May 13, 2020	BUY	$63.18 - $85.97 $3.03 Million - $4.12 Million	47,927 New	47,927 $3.51 Million
Q4 2019 Feb 11, 2020	SELL	$73.04 - $95.72 $167,992 - $220,156	-2,300 Reduced 4.56%	48,154 $4.21 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $3.64 Million - $4.32 Million	-49,929 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $3.36 Million - $4.05 Million	45,635 Added 1062.76%	49,929 $4.24 Million
Q1 2019 May 10, 2019	SELL	$63.56 - $88.17 $2.9 Million - $4.02 Million	-45,635 Reduced 91.4%	4,294 $49.9 Million
Q4 2018 Jan 31, 2019	BUY	$58.5 - $69.94 $2.92 Million - $3.49 Million	49,929 New	49,929 $3.18 Million
Q3 2018 Nov 14, 2018	SELL	$61.75 - $74.23 $1.22 Million - $1.46 Million	-19,717 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$60.85 - $83.98 $155,350 - $214,400	2,553 Added 14.87%	19,717 $1.32 Million
Q4 2017 Feb 06, 2018	SELL	$93.56 - $116.6 $9,449 - $11,776	-101 Reduced 0.58%	17,164 $1.63 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,963 Added 20.72%	17,265 $2.17 Million
Q1 2017 Nov 28, 2017	BUY	N/A	2,690 Added 23.17%	14,302 $1.91 Million
Q3 2016 Dec 04, 2017	BUY	N/A	11,612	11,612 $1.16 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Account